molecular science

Irving’s Caris Life Sciences Closes On $400M Secured Term Loan

by | Jan 23, 2023

Caris Life Sciences, the Irving-based biotech company, announced Thursday that it closed a senior secured term loan providing up to $400 million in capital from OrbiMed and Braidwell, bringing its funding total since 2018 to roughly $1.7 billion.

Caris, a molecular science and technology company that is actively developing and delivering innovative solutions to revolutionize healthcare, said it will use the proceeds to repay debt, improve its unique precision medicine platform, and for general corporate purposes....

MORE
Caris Life Sciences
Caris Life Sciences Launches AI-Driven Profiling Tool for Tumors
by | Dec 12, 2019
The Genomic Profiling Similarity Score uses over 6,500 mathematical models in a machine learning algorithm to compare molecular characteristics of a patient's tumor against Caris' extensive database.
MORE
Follow the money concept [Illustration: Sergey Khakimullin/istockphoto]
Follow the Money: Caris Raises $150M, Meritize Gets $13.2M, iDonate Secures $10M, BenefitMall Buys Phoenix Firm
by | Oct 4, 2018
From Dallas investor Carl Sparks and 7-Eleven Ventures to Conversable and Hospice Source, here are notable funding and acquisition deals with North Texas ties.
MORE